Sanara MedTech Inc.
General ticker "SMTI" information:
- Sector: Health Care
- Industry: Medical - Instruments & Supplies
- Capitalization: $226.9M (TTM average)
Sanara MedTech Inc. does not follow the US Stock Market performance with the rate: -11.6%.
Estimated limits based on current volatility of 2.5%: low 21.41$, high 22.49$
Factors to consider:
- Total employees count: 108 (+4.9%) as of 2023
- Top business risk factors: History of losses, Strategic risks and growth management, Liquidity and credit risks, Product defects, Security breaches
- Price in estimated range
- Earnings for 3 months up through Q1 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [15.81$, 33.42$]
- 2026-12-31 to 2027-12-31 estimated range: [14.83$, 31.47$]
Financial Metrics affecting the SMTI estimates:
- Negative: with PPE of -47.6 at the end of fiscal year the price was very high
- Positive: 7.54 < Operating profit margin, % of 8.87
- Positive: -0.02 < Operating cash flow per share per price, % of 3.24
- Negative: negative Net income
- Positive: Inventory ratio change, % of 0.61 <= 0.78
- Positive: Interest expense per share per price, % of 3.23 <= 3.31
- Positive: -0.03 < Industry operating cash flow per share per price (median), % of 1.51
- Negative: Industry operating profit margin (median), % of -3.62 <= 2.88
Short-term SMTI quotes
Long-term SMTI plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $64.99MM | $86.67MM | $103.12MM |
| Operating Expenses | $69.20MM | $93.39MM | $93.97MM |
| Operating Income | $-4.22MM | $-6.72MM | $9.15MM |
| Non-Operating Income | $-0.22MM | $-3.20MM | $-9.54MM |
| Interest Expense | $0.48MM | $3.13MM | $6.76MM |
| R&D Expense | $4.13MM | $5.70MM | $5.07MM |
| Income(Loss) | $-4.44MM | $-9.91MM | $-0.39MM |
| Net Income(Loss)* | $-4.30MM | $-9.66MM | $-37.56MM |
| Stockholders Equity | $44.83MM | $39.40MM | $5.94MM |
| Inventory | $4.72MM | $2.75MM | $3.95MM |
| Assets | $73.87MM | $88.09MM | $72.94MM |
| Operating Cash Flow | $-3.25MM | $-0.02MM | $6.79MM |
| Capital expenditure | $0.27MM | $0.23MM | $4.63MM |
| Investing Cash Flow | $-10.21MM | $-6.61MM | $-14.97MM |
| Financing Cash Flow | $9.64MM | $17.37MM | $8.89MM |
| Earnings Per Share** | $-0.52 | $-1.14 | $-4.36 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.